T3 Companies’s Basel Medical BMGL Stock Holding History

T3 Companies’s Portfolio BMGL Stock Details BMGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,250	Closed	-$8.85K	–	253
2026 Q1	$8.85K	Buy	+1,250	New	+$9.89K	0.01%	120

Other funds holding BMGL

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

T3 Companies's BMGL Position: Q2 2026 in Review

T3 Companies sold out of Basel Medical (BMGL) in Q2 2026, closing a stake of 1,250 shares — an estimated $8.85K sold.

T3 Companies first reported a position in BMGL in Q1 2026 and held it in 1 quarter. The position peaked at $8.85K in Q1 2026. 2 funds tracked by Wall St. Rank hold BMGL as of Q2 2026.

T3 Companies reported no remaining Basel Medical position as of Q2 2026 after selling out during the quarter.
T3 Companies sold 1,250 Basel Medical shares in Q2 2026, an estimated $8.85K.
T3 Companies first reported a position in Basel Medical in Q1 2026 and held it in 1 quarter.
T3 Companies's Basel Medical position peaked at $8.85K in Q1 2026.
2 funds tracked by Wall St. Rank held Basel Medical as of Q2 2026.

Based on T3 Companies's 13F filing for Q2 2026, filed 27 Jul 2026.